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Background
Circulating angiotensin-2 levels (A2) protect the circula-
tion against sudden falls in blood pressure. A2 is gener-
ated by the enzymatic action of angiotensin converting
enzyme (ACE) on angiotensin-1. The ACE genes have 2
allellic forms, with the presence ‘I’ or absence ‘D’ of a
287 base pair intron of the gene. The deletion ‘DD’ gen-
otype is associated with high A2 generation & higher
serum ACE levels, while the insertion ‘II ’ with lower
serum ACE levels & ACE activity.
Aim
To examine whether these 2 inherited polymorphisms
have a different profile in patients with past anaphylaxis
we compared this with control groups which included
the measurement of serum ACE levels. Method: A total
of 286 subjects were analysed. 118 had previous anaphy-
laxis, 119 were healthy controls, 49 were atopic without
any previous anaphylaxis. DNA extracted from EDTA
blood was analysed for ACE gene polymorphisms using
polymerase chain reactions, followed by gel electrophor-
esis to identify the genotypes. Serum ACE levels were
also measured (normal range 20-70 U/l).
Results
See table 1 including p values from chi squared analysis.
No statistical differences were found between ‘Atopics’
& HC, but significant differences in the genotype fre-
quency were seen between subjects with anaphylaxis
and HC.
Dividing the anaphylaxis group into 2 subgroups,
there were significant differences between those with
airway angio-oedema +/- cardiovascular collapse
(AACVS) which is likely to be linked to ACE activity &
bradykinin effects, & HC; but not between HC & cuta-
neous & mild respiratory symptoms (CRS) only, where
histamine & not ACE is likely to be involved.
The AACVS & CRS subgroups were significantly dif-
ferent; p=0.001. In AACVS collapse was more likely to
be associated with ID, O.R. 3.3 (95% CI 1.7, 6.3) or II,
O.R. 3.1 (95% CI 1.4, 6.9) than DD genotypes p=0.001.
Atopics showed a similar tendency towards a lower pre-
valence of DD but this was of borderline significance
p=0.0821.
Physiological studies show the blood pressure
responses & serum ACE levels are identical for the ID
& II genotypes, with only a double dose of the “D” gene
resulting in higher serum ACE levels & activity giving
rapid vasoconstrictor responses in hypotension. In
women, there is a higher prevalence of anaphylaxis com-
pared with men. Interestingly the activity of the D gene
is inhibited by oestrogen at the messenger RNA level, &
offers cardiovascular protection against heart disease
which is lost in the menopause when oestrogen falls.
Serum ACE levels were similar in HC & Atopics
p=0.0866, in keeping with the similar genotype. Anaphy-
laxis subjects had lower levels compared with HC
(p=0.012) & atopic (p=0.0022) reflecting the difference
in genotype.
Conclusion
The results show a significant change in the genotype
frequency between the HC, atopics and subjects who
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AACVS. These changes show a reduction in DD geno-
t y p e&i n c r e a s e si nI D&I I,b o t ho fw h i c ha r ea s s o -
ciated with lower Serum ACE levels & ↓ activity. Such
findings may help to explain the cardiovascular collapse
& airway angio-oedema in such cases.
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Table 1
ACE genotype D D I D I I Healthy
Controls
Atopics Anaphylaxis Cutaneous
&R S
Mean Serum ACE
Levels U/L±SEM
Serum ACE V’s
Healthy Controls
Healthy controls (HC)
N=119 (%)
53
(45%)
44
(37%)
22
(18%)
P=0.142 P=0.009 P=0.053 48.9±6.2
Atopic controls N=49 (%) 15
(31%)
26
(53%)
8
(16%)
P=0.142 P=0.425 P=0.025 47.9±3.5 P=0.866
Anaphylaxis N=118 (%) 30
(25%)
58
(50%)
30
(25%)
P=0.009 P=0.425 33.2±3.0 P=0.012
Cutaneous & Respiratory
anaphylaxis
15
(56%)
12
(44%)
0
(0%)
P=0.053 P=0.025
Airway angioedema ±
CVS collapse
13*
(14%)
46
(52%)
30
(34%)
P<0.001 P=0.024 P<0.001
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